Copyright
©The Author(s) 2024.
World J Gastroenterol. Sep 7, 2024; 30(33): 3837-3845
Published online Sep 7, 2024. doi: 10.3748/wjg.v30.i33.3837
Published online Sep 7, 2024. doi: 10.3748/wjg.v30.i33.3837
Number of patients included | 67 |
Gender, male | 37 (55) |
Age at transplant (months), median (IQR) | 11.9 (7.7 to 24.6) |
Weight at transplant (kg), median (IQR) | 7.4 (6.4 to 11.5) |
Z-score BMI, median (IQR) | -0.4 (-1.3 to -1.0) |
PELD score, median (IQR) | 14 (6 to 22) |
GRWR (%), median (IQR) | 3.2 (2.5 to 4.0) |
Transplant modality | |
Living donor | 60 (90) |
Deceased donor | 7 (10) |
Baseline disease | |
Biliary atresia | 38 (57) |
Acute liver failure | 3 (4.4) |
Alagille syndrome | 6 (9) |
Primary liver tumor | 4 (6) |
Other | 16 (24) |
- Citation: Melere MU, Feier FH, Neumann J, Kalil AN, Montagner JM, Nader LS, da Silva CS, Junior MAF, Coral GP, Bobsin GP, Ferreira CT. Human leukocyte antigen compatibility and incidence of donor-specific antibodies in pediatric liver transplant recipients. World J Gastroenterol 2024; 30(33): 3837-3845
- URL: https://www.wjgnet.com/1007-9327/full/v30/i33/3837.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i33.3837